ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0811

SSc Skin Cell Atlas: a Scalable Web Portal for scRNA-Seq Analysis

Helen Jarnagin1, Zhiyun Gong1, Rachael Bogle2, Alex Tsoi2, Rezvan Parvizi3, Madeline Morrisson4, Dinesh Khanna5, Johann Gudjonsson5 and Michael Whitfield6, 1Dartmouth College, Lebanon, NH, 2University of Michigan, Holland, OH, 3Dartmouth, lebanon, NH, 4Geisel School of Medicine at Dartmouth College, Hanover, NH, 5University of Michigan, Ann Arbor, MI, 6Geisel School of Medicine, Lebanon, NH

Meeting: ACR Convergence 2025

Keywords: Gene Expression, genomics, Scleroderma, Scleroderma, Systemic, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: Abstracts: Systemic Sclerosis & Related Disorders – Basic Science (0807–0812)

Session Type: Abstract Session

Session Time: 2:00PM-2:15PM

Background/Purpose: Despite the recent popularity and utility of modern high-resolution sequencing technologies, leveraging publicly available single-cell studies remains hampered by the need for substantial computational power and expertise. In this study, we assembled and integrated publicly available single-cell datasets from diffuse cutaneous systemic sclerosis (dcSSc) skin and control samples. The processed data, accessible through a web application, enables users to access and perform single-cell analyses without prior coding expertise or high-performance computing resources.

Methods: Single-cell counts and metadata were downloaded from the GEO repositories for each dataset (Table 1); each was then processed and normalized independently using Seurat. Cell typing was performed, hierarchically and then subclustered for detailed analysis (differential expression, CAMML, and SingleR). Gene set enrichment was performed on each dataset and cell subpopulation (VAM). Differential expression and gene set enrichment comparisons were performed using the Wilcoxon Rank Sum test. A cohort of these datasets were processed using uniform genome alignment and counts generation (CellRanger 9.0.0, GRCh38) to generate a novel integrated dataset for disease-based comparisons at a single-cell level.

Results: We standardized and reprocessed all publicly available single-cell datasets analyzing dcSSc skin biopsies. These data were optimized for efficient loading into a user-friendly web interface for gene expression and pathway querying (Fig. 1a-c). From individual objects, we successfully recapitulated the findings presented in the original primary research articles, such as the enrichment of SFRP4 in specific fibroblast subpopulations (Wilcoxon Rank Sum Test, p.adjust = 3.9e-151) (Fig 1d). This tool also enables gene set enrichment tests in specific cell subtypes that were not previously presented in the original manuscripts, such as the enrichment of the complement system in SSc macrophages (Wilcoxon Rank Sum Test, p.adjust 1.95e-203) (Fig. 1e-f). Finally, we generated a fully integrated single-cell dataset across multiple studies as a novel source for comparing SSc skin samples.

Conclusion: The SSc Skin Single Cell Atlas is a user-friendly web application for rapid and detailed analysis of publicly available datasets. This tool enables users to easily ask questions regarding gene and gene set differential expression without the need to download, process, and analyze the data locally. Furthermore, given the heterogeneous nature of SSc, accessing a large cohort of patients for single-cell comparison is paramount to better understand cellular dynamics that drive SSc fibrosis. This novel study integrates publicly available datasets from multiple research reports to provide a more comprehensive understanding of SSc skin fibrosis.

Supporting image 1

Supporting image 2


Disclosures: H. Jarnagin: None; Z. Gong: None; R. Bogle: None; A. Tsoi: Galderma, 5, Johnson and Johnson, 5; R. Parvizi: None; M. Morrisson: None; D. Khanna: Argenx, 2, AstraZeneca, 2, Boehringer-Ingelheim, 2, Bristol-Myers Squibb(BMS), 2, Cabaletta, 2, Novartis, 2, UCB, 2, Zura Bio, 2; J. Gudjonsson: None; M. Whitfield: Boehringer Ingelheim, 1, 2, Bristol-Myers Squibb(BMS), 2, Celdara Medical LLC, 2, 5, 10, 12, Scientific Founder.

To cite this abstract in AMA style:

Jarnagin H, Gong Z, Bogle R, Tsoi A, Parvizi R, Morrisson M, Khanna D, Gudjonsson J, Whitfield M. SSc Skin Cell Atlas: a Scalable Web Portal for scRNA-Seq Analysis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/ssc-skin-cell-atlas-a-scalable-web-portal-for-scrna-seq-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ssc-skin-cell-atlas-a-scalable-web-portal-for-scrna-seq-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology